Evidence map›Paper›PMID 39693209›Full record

ArticleInternational journal of cancer2025

A novel mouse model of upper tract urothelial carcinoma highlights the impact of dietary intervention on gut microbiota and carcinogenesis prevention despite carcinogen exposure.

Akinaru Yamamoto, Atsunari Kawashima, Toshihiro Uemura, Kosuke Nakano, Makoto Matsushita, Yu Ishizuya, Kentaro Jingushi, Hiroaki Hase, Kotoe Katayama, Rui Yamaguchi and 21 more

Abstract read
In one paragraph

Article in International journal of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. The Urinary Microbiota and the Gut-Bladder Axis in Bladder Cancer.International journal of molecular sciences · 2025
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Akinaru YamamotoDepartment of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.ORCID 0000-0002-3565-5870
Atsunari KawashimaDepartment of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Toshihiro UemuraDepartment of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Kosuke NakanoDepartment of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.ORCID 0000-0001-5356-7359
Makoto MatsushitaDepartment of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.ORCID 0000-0002-7491-9410
Yu IshizuyaDepartment of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Kentaro JingushiLaboratory of Molecular and Cellular Physiology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.ORCID 0000-0002-2274-4962
Hiroaki HaseLaboratory of Molecular and Cellular Physiology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.
Kotoe KatayamaLaboratory of Sequence Analysis, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID 0000-0002-3966-1231
Rui YamaguchiDivision of Cancer Systems Biology, Aichi Cancer Center Research Institute, Nagoya, Japan.
Nesrine SassiDepartment of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Yuichi MotoyamaDepartment of Pathology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Satoshi NojimaDepartment of Pathology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Masashi MitaKAGAMI Inc., Ibaraki, Osaka, Japan.
Tomonori KimuraDepartment of Nephrology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Daisuke MotookaDepartment of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Yuki HoribeDepartment of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Yohei OkudaDepartment of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Toshiki OkaDepartment of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Gaku YamamichiDepartment of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Eisuke TomiyamaDepartment of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Yoko KohDepartment of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Yoshiyuki YamamotoDepartment of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Taigo KatoDepartment of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Koji HatanoDepartment of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Motohide UemuraDepartment of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Seiya ImotoLaboratory of Sequence Analysis, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Hisashi WadaDepartment of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Eiichi MoriiDepartment of Pathology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Kazutake TsujikawaLaboratory of Molecular and Cellular Physiology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.
Norio NonomuraDepartment of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.ORCID 0000-0002-6522-6233

Funding

Japan Agency for Medical Research and Development JP22ym0126809i0002Japan Agency for Medical Research and Development JP23ama121054Japan Society for the Promotion of Science 19K09709Japan Society for the Promotion of Science 21K20968Japan Society for the Promotion of Science 22H03213Japan Society for the Promotion of Science 22K09523Japan Society for the Promotion of Science 22K18398
6 · The paper itself

Abstract

Animal models of N-butyl-N-(4-hydroxy butyl) nitrosamine (BBN)-induced urothelial carcinoma (UC), particularly bladder cancer (BC), have long been established. However, the rare incidence of BBN-induced upper urinary tract UC (UTUC), which originates from the same urothelium as BC, remains elusive. The scarcity of animal models of UTUC has made it challenging to study the biology of UTUC. To address this problem, we tried to establish a novel mouse model of UTUC by treating multiple mice strains and sexes with BBN. The molecular consistency between the UTUC mouse model and human UTUC was confirmed using multi-omics analyses, including whole-exome, whole-transcriptome, and spatial transcriptome sequencing. 16S ribosomal RNA metagenome sequencing, metabolome analysis, and dietary interventions were employed to assess changes in the gut microbiome, metabolome, and carcinogenesis of UTUC. Of all treated mice, only female BALB/c mice developed UTUC over BC. Multi-omics analyses confirmed that the UTUC model reflected the molecular characteristics and heterogeneity of human UTUC with poor prognosis. Furthermore, the model exhibited increased Tnf-related inflammatory gene expression in the upper urinary tract and a low relative abundance of Parabacteroides distasonis in the gut. Dietary intervention, mainly without alanine, led to P. distasonis upregulation and successfully prevented UTUC, as well as suppressed Tnf-related inflammatory gene expression in the upper urinary tract despite the exposure to BBN. This is the first report to demonstrate a higher incidence of UTUC than BC in a non-engineered mouse model using BBN. Overall, this model could serve as a useful tool for comprehensively investigating UTUC in future studies.

Indexed as

Gastrointestinal MicrobiomeUrinary Bladder NeoplasmsUrologic NeoplasmsAnimalsButylhydroxybutylnitrosamineCarcinogenesisCarcinogensDisease Models, AnimalFemaleHumansMaleMiceMice, Inbred BALB CUrotheliumButylhydroxybutylnitrosamineCarcinogensanimal modelcancer preventionmicrobiomeN‐butyl‐N‐(4‐hydroxybutyl) nitrosamineupper tract urothelial carcinoma

Identifiers

PMID39693209
PMCPMC11789449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.